Current role
Shane Campbell
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Shane Campbell
West Pharmaceutical Services Inc reported in an 8-K filed April 24, 2025 that Shane Campbell was appointed Senior Vice President, Chief Proprietary Segment Officer, effective May 5, 2025.
“On April 24, 2025, the Company announced that it had appointed Shane Campbell to serve as Senior Vice President, Chief Proprietary Segment Officer, effective May 5, 2025 (the "Commencement Date").”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2025-05-05–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at West Pharmaceutical Services Inc
Other people whose current roles at this company are on record from its filings.
- Michel Lagarde CEO, Board Member
- Robert F. Friel Chairman, Board Member
- Kimberly Banks MacKay General Counsel
- Chad R. Winters Chief Accounting Officer
- CURRENT Merus N.V Board Member
- Deborah L. V. Keller Board Member
- Douglas A. Michels Board Member
- Janet Haugen Board Member
- Mark A. Buthman Board Member
- Molly E. Joseph Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.